▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2947 by analyst upside · 2026-06-26
ALHC
Alignment Healthcare, Inc.
Healthcare · Market Cap $5B · P/E 227.1x
ANALYST PRICE TARGET
+9.7%
implied upside to consensus target
Current Price $22.71
Consensus Target $24.92
Bull Target $30.0
Bear Target $16.0
Analysts Covering 13
ANALYST CONSENSUS — BUY
Strong Buy
2
Buy
9
Hold
2
Sell
0
52-Week Low $11.62
52-Week High $23.87
YTD Return +12.3%
FUNDAMENTALS
Market Cap $5B
P/E Ratio (TTM) 227.1x
Forward P/E 31.4x
EPS (TTM) $0.10
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $4.3B
Profit Margin 0.5%
52-WEEK RANGE
52-Week Low $11.62
52-Week High $23.87
Current Price $22.71
Bear Target $16.0
Bull Target $30.0
● Now $22.71 ● Target $24.92
TRADING DATA
Avg Volume 5.5M
YTD Return +12.3%
Analyst Count 13
Consensus Buy
Upside to Target +9.7%
Last Updated 2026-06-26

ANALYST SUMMARY

Alignment Healthcare, Inc. (ALHC) is currently trading at $22.71 with a Wall Street consensus price target of $24.92, implying potential upside of 9.7% over the next 12 months. 13 analysts currently cover ALHC, with a consensus rating of Buy — 85% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $30.0, while the most cautious has a target of $16.0.

ALHC operates in the Healthcare sector with a market capitalisation of $5B. The stock is up 12.3% year-to-date and is currently trading near the upper end of its 52-week range of $11.62 – $23.87.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

BLLN -0.4%
BillionToOne, Inc.
$5B · P/E 207.3x · Buy
LFST +2.6%
LifeStance Health Group, Inc.
$4B · P/E 171.3x · Buy
CORT +0.8%
Corcept Therapeutics Incorporated
$9B · P/E 249.5x · Buy
PRVA +22.9%
Privia Health Group, Inc.
$3B · P/E 150.4x · Buy
RGEN +19.8%
Repligen Corporation
$8B · P/E 159.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ALHC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-05-26 Building track record
UBS — Reiterated
Neutral → Neutral 2026-05-01 33% win rate (6 calls)
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-02-05 43% win rate (7 calls)
TD Cowen — Reiterated
Buy → Buy 2026-01-16 Building track record
UBS — Reiterated
Neutral → Neutral 2026-01-14 33% win rate (6 calls)
Piper Sandler — Reiterated
Overweight → Overweight 2026-01-06 14% win rate (7 calls)
JP Morgan — Reiterated
Overweight → Overweight 2025-12-17 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →